CA1275976C - Device for the administration of medicament suspensions - Google Patents

Abstract

Abstract of the disclosure Medicament containers, particularly injection ampules, for multiple administration of medicament suspensions en-sure, even when filled so as to be free of gas bubbles, simple homogenization of the suspension when they contain inert mixing elements of suitable size whose density is sufficiently different from that of the suspension.

Description

~2~

HOECHST AKTIENGESELLSCHAFT Dr.SW/gm HOE 86/F 048 Device for the administration of medicament suspensions Portable ;nfusion dev;ces are known for automat;c deliv-ery of liquids, particularly insulin, lhese liquids being contained in replaceable injection amp~les (European Patent Application 0,143,895, and the devices ~entioned therein). Portable multidose injection devices, so-called "pens" (EP-A 0,058,536 and WO 82/02,662) are fur-thermore known. However~ these known dev;ces, which are intended for multiple administration of the medicaments, are only suitable for homogeneous liquids, particularly solu-tions~ In the case of disperse systems, such as medica-ment suspensions, the danger exists not only that crystalsettling causes mechanical problems, but, above all, in-- correct dosages are caused. Such incorrect dosages are particularly critical when the med;cament is a h;ghly-active medicament of narrow therapeutic range, such as, for example, insulin.

If, in the case of an insulin suspension, too few crys-taLs are administered because the suspension has been in-adequately shaken or has already settled again~ hyper-glycemia is to be expected, along with the known accom-panying symptoms and with increased risk of later compli-cations. If, in contrast, too much of the active ingred-ient 7S administered, hyperinsulinemia and hypoglycemia are to be feared, along with the accompanying serious symptoms, such as sweating, cramps and unconsciousness, up to death caused by hypoglycemic shock.

Medicament suspensions are usually filled into containers which also contain a gas space above the suspension. The 3S suspension san then be homogen;zed by rolling, ;nverting ar shaking this container. The presence of the gas bub-ble and it~ mobility is responsible for this. If, in contrast, the suspension is f;lled so that there is essentially no gas space, for example in cylindrical ` ~27~i~7~

ampules from which multiple administrations are to take place, homogeneous mixing is normally not possible in a reasonable time. The physical basis for this phenomenon is that the density of crystals is generally very simi-;; 5 lar to the density of the medium.

In the case of dispensing devices in which multiple dosesare to be administered from a stock, essentially gas bub-ble-free filling is necessary, however, since only then is reproduceable dose administration ensured. "Essen-tially gas bubble-free" here is not intended to exclude a msre or less large amount of gas being present initial-ly, that is to say, for example, in the initial ampule~
which is, however, removed in a known fashion before the ~_ 15 first administration so that the liquid is then virtually free of gas bubbLes. Houever, gas bubble-free crystal suspensions cannot be converted into the necessary homo-geneous form by shaking in an acceptable per;od of time.
It should particularly be taken into account here that such a homogenization must also be possible for old and handicapped patients. The object of the invention was thus to provide storage containers which are suitable ~or infusion and ;njection dev;ces and in ~hich medica-ment suspens;ons can also be homogenized by shaking in the absence of a gas bubble~
~ :
~ This is complicated by the fact that the sterility of the ;~ contents necessary for parentaL administration must be ensured. The storage container must therefore be de-signed so that it can be sterilized, when fil~ed, using ~he conventional processes, or, after sterilization of the individual parts, it can be asse~bled, filled with sterile medicament suspension and sealed, all under as-ceptic conditions.

.
It is known that lubricant dispersions and paints which are filled into spray cans contain steel balls as mixing elements. However, the lubricants are easily dispersible subst~nces, such as molybdenlls sulf;de and graph;te, , , ~7~37~

which can easi~y be converted into a sprayable form by a few shaking movements In contrast, a re~atively viscous system is present in the case of paints, meaning that high shear forces, which s;mplify redispersal~ are pro-duced on shaking. In addition, these systems containlarge amounts of propellent gas, meaning that this type of mixing cannot easily be appLied to medicament suspens-ions. In addition, metal abrasion occurs caused by the - friction of the steel bal~s on the wall of the container, but this does not interfere in the case of these indus-trial systems. The danger of recrystallization and thus particle enLargement does not exist ei~her, since the dispersed lubricants or pigment particles are completely or virtually insoluble in the administration medium.
- Due to the lack of a gas space and - particuLarly in the case of cylindrical ampules - due to the unfavorable ratio of diameter to length, which, in addition~ changes constantly during use when the piston is advance~, it was not to be expected tha~ simple mixing elements, as are known from spray cans, could also be suitab~e for homogenization in medicament suspensions which are filled into conventiona~ medicament containers without gas bub-ble ~5 In addition, it is known that many medicament crystals - particularly insuLin - are sensitive to mechanical load. If, for examp~e, an insuLin crystal suspension is stirred in a heaker on a conventional magnetic stirrer, a noticeable proportion of the insulin crysta~s are triturated due to the action of the magnetic follower. The ;ncrease in the surface of the particles which ;s connected with this causes their dissolution rate, and thu the depot effect, to be al~ered in an undesired fashion. Such an alteration of the particle size ~as a~so feared in the use of ~ixing elements in medicament containers~
.
Surprisin~ly, it has now been found that even medicament ~7~6 suspensions, above all those which are filled so as to be free of gas bubbles, can easily be converted into a homo-geneous suspension with the aid of mixing elelnents i~ the mixing element is inert, has a su;table size, an~ has a density which is sufficiently different to that of the medicament suspension. All the parameters mentioned are easily determined here by simple prelimin3ry experiments.
A sufficiently different dens;ty is taken as being when ~ the density of the mixing element is at least 10~, pref--~ 10 erably at least 5Q%, particularly at least 100%, greater than that of the suspended medicament~
:
Surpris;ngly, the particle size of insulin crystal sus-pensions, as are used in the examples shown below, are - 15 virtually unaltered under the conditions described.

` Since the med;cament containers, above all injection am- pules, for example conventional cylindrical ampules or tw;n-chamber syringes (for example Pharm. Ind. 46 (1984, No. 3) 317), are usually made of glass, the mixing ele-ments are advantageously likewise manufactured from glass However~ plastics, for example polymers of fluorinated ~; ethylenes, such as PTFE, or ceramic or metallic, option-ally coated elements are also su;table.
~- The shape of the mixing ele~ent can be optim;zed by ap-~ propr;ate prel;m;nary experiments, care being taken, ex-;~; pediently, that the volume of the mixing element remains smal( co~pared to the reservoir, so that comparatively small dead spaces are produced~ In generaL, simple shapes are su;table for the mixing elements, such as cyl-inders~ or, preferably, spheres, but molded articles hav-ing a turbulence-generating surface shape, such as spheres with holes, or other complicated shapes are also possib~e~
"Inert" is taken to mean a mix;ng element wh;ch ;nteracts ne;ther chemically nor phys;cally in an interfer;ng man-ner ~ith the medicament preparation~ Thus~ ne;ther a chem;cal chan~e nor a phys;cal impa;rment, such as , .
.

: , .

: `

~275~7~;

adsorption or abrasion, may occur to a significant extent.

In the contex~ of the invention, a system which permits homogenization by shaking using few tilting or shak;ng S movements ;s thus suitable.

The invention is described in greater detail in the fol-lowing examples.

In all examples and comparison examples, the cylindrical ampules (1), represented schematically in the figure, are employed which have, at the top, a movable piston (2)on which can act 3 piston rod ~not represented). The ampule ;s fiLled with the medicament suspension (3) so _ 15 as to be bubble-free and conta;ns one or more mixing ele-ments (4). In the figure, a sphere is represented as mixing element. The outlet piece (S) is sealed in a known fash1on.

An aqueous depot insul;n preparation (Basal H Insulin U-100 HoechstR) which contains û.1 I.U~ per ~l of insulin is used as medicament suspension. The ease o~ shaking up the sediment was assessed visually, after a standing time of 12 hours (inverted), by means of tilting movements of 1aO

In comparison examples 1 to 3 and examples 1 to 4, the cylindrical ampules (1) had a length of 62.3 mm and an internal diameter of 6.85 mm.
Comparison example 1 No addition of glass beads.

Assessment: Homogenization by shaking up by means o~ s;m-~; ple tilt;ng movements not possible in an acceptable period of time~
':
- .;

.

: . ' ~s~
-- , Comparision example 2:

Addition of one glass bead of diameter 3 mm.

S Assessment~ Ease of shaking-up not reproduceable.
Sediment got into the outlet part of ~he cylindrical ampule along with a sphere and wedged the sphere there.

Comparison exa_ple 3:

Addition of two glass beads, diameter 3 mm.

Assessment: As in comparison example 2.
_ 15 Example 1-Addition of one glass bead df d;ameter 4 mm.

Assessment: Homogenization by shaking by means of 6 to 9 tilting movements.
.~ .
Example 2:
:
Addition of two glass beadsr diameter 4 mm.

Assessment: As in example 1.

~ Example 3:

~; Addition of one glass bead of diameter 5 mm.

Assessment: Homogenization by shak;ng by means of 3 to 4 tilting movements.
Example 4:

Addition of one glass bead of diameter 6 mm.

Assessment: As in example 3.

~75i97~

Examples 5 and 6:

Cylindrical ampules, of length 58 mm and internal diam-eter 6.85 mm, which contained one glass sphere (diameter 5 mm) were filled with the insulin suspension so as to be free of gas bubbles and were employed in a commerc-ially available insulin "pen".

.
After different standing times between w;thdrawals, the contents were resuspended by means of five 180 tilt-ing movements, and 40 ~l, corresponding to 4 i.U. oF
insulin, were dispensed into each o~ five sample tubes.
The insulin content of the individual samples was deter-mined analytically in order to ascertain the homogeneity.
The mean value (x) of Five samples in each case and the relative standard deviation (Srel) are colLated ;n the following table from t~o parallel experimental series with two insulin "pensl':

:
Standing time x (I.U.) Srel (X) before resus- ----------------------------------------~-~ pending Example 5 Example 6 Example S Example 6 :' ~
~ 25 . ~
6 hours 4.4 3.9 1t.1 5.6 72 hours 4.1 4.0 8.4 1.2 6 hours 3.9 4.0 2~3 3.3 3016~hours 3.7 4.0 4.Q 5.7 ' ' ~-: : .

~ ~ .

Claims (11)

1 A device for the administration of medicament suspensions, comprising a container (1), which is filled with a suspension (3) and contains one or more mixing elements (4) which are inert towards the suspension, have a density which is sufficiently different to that of the suspension, and the dimensions of which are such that the suspension is homogenized by means of few shaking movements

2. The device as claimed in claim 1, comprising a cylindrical container (1) which is sealed at the top by a movable piston (2) and at the bottom by an outlet piece (5).

3. The device as claimed in claim 1, wherein the mixing element or elements (4) are spherical.

4. The device as claimed in claim 1, 2 or 3, contain-ing one to 3 spherical mixing elements.

5. The device as claimed in claim 1, 2 or 3, wherein the density of the mixing element (4) is at least 10% greater than that of the suspension (3).

6. The device as claimed in claim 1, 2 or 3, wherein the density of the mixing element (4) is at least 50% greater than that of the suspension (3).

7. The device as claimed in claim 1, 2 or 3, wherein the density of the mixing element (4) is at least 100% greater than that of the suspension.

8. The device as claimed in claim 1, wherein the mixing element (4) comprises glass, metal, plastic or ceramic.

9. The device as claimed in claim 8, wherein the mix-ing element is coated.

10. The device as claimed in claim 1, 2 or 3, wherein the suspension (3) is a crystal suspension.

11. The device as claimed in claim 1, 2 or 3, wherein the suspension (3) is an insulin crystal suspension.